DPH1

DPH1 is the catalytic subunit of a radical S-adenosylmethionine (SAM) enzyme that initiates diphthamide biosynthesis on elongation factor 2 (EF-2), a unique post-translational modification essential for translational fidelity, sensitivity to diphtheria toxin, and normal development. DPH1 forms an obligate heterodimer with DPH2, in which the DPH1-bound [4Fe-4S] cluster serves the catalytic radical SAM role—cleaving SAM to generate the 3-amino-3-carboxypropyl radical that forms a C–C bond with a conserved histidine on EF-2—while the DPH2 cluster relays electrons from the Dph3/Cbr1/NADH donor system (PMID:24422557, PMID:31463593). Dph3 additionally donates iron to convert an air-degraded [3Fe-4S] cluster back to a functional [4Fe-4S] state, enabling aerobic activity (PMID:34154323). Tandem cysteine motifs and a SAM-binding pocket in DPH1 are critical for cluster stability, SAM cleavage, and diphthamide synthesis (PMID:38672486, PMID:38002337), and loss-of-function variants in DPH1 cause DPH1 syndrome, a developmental disorder featuring craniofacial defects attributable to impaired diphthamide modification in neural crest cells (PMID:24895408, PMID:30877278).

1. 1999 Medium

   The initial observation that OVCA1/DPH1 overexpression suppresses proliferation via G1 arrest and cyclin D1 degradation established it as a candidate growth-regulatory gene, though the molecular mechanism was unclear.

   Evidence Stable transfection in ovarian cancer cells with FACS and cyclin D1 rescue

   PMID:10519411

   Open questions at the time

   • No connection to diphthamide or EF-2 modification was established
   • Mechanism linking DPH1 to cyclin D1 turnover was not identified
   • Overexpression-only, no loss-of-function data
2. 2004 High

   Mouse knockout studies established that DPH1 loss causes cell-autonomous proliferation defects rescuable by p53 deficiency, placing DPH1 upstream of or parallel to p53 in cell-cycle control, but the biochemical function remained unknown.

   Evidence Ovca1-null and Ovca1;p53 double-mutant mice, MEF proliferation assays

   PMID:14744934

   Open questions at the time

   • Biochemical activity of DPH1 was still uncharacterized
   • Whether growth suppression reflects diphthamide deficiency or another function was unknown
3. 2005 High

   Gene-trap mutagenesis in CHO cells demonstrated that DPH1 is required for diphthamide modification of EF-2, definitively placing it in the diphthamide biosynthetic pathway and explaining diphtheria toxin resistance upon DPH1 loss.

   Evidence Gene trap mutagenesis with diphtheria toxin and Pseudomonas exotoxin A resistance assays

   PMID:15637051

   Open questions at the time

   • Whether DPH1 acts enzymatically or as a scaffold was unknown
   • The relationship between diphthamide loss and the proliferation/developmental phenotypes was not addressed
4. 2014 High

   In vitro reconstitution revealed that the Dph1–Dph2 heterodimer is the radical SAM enzyme catalyzing the first step of diphthamide biosynthesis—ACP transfer from SAM to EF-2 histidine—with Dph3 serving as the electron donor to reduce the Fe-S cluster.

   Evidence In vitro reconstitution with purified yeast Dph1–Dph2, EPR spectroscopy

   PMID:24422557

   Open questions at the time

   • Which subunit harbors the catalytic vs. electron-relay cluster was not resolved
   • The SAM-binding site had not been mapped
5. 2014 High

   Conditional knockout in mice showed that DPH1-dependent diphthamide biosynthesis is specifically required in neural crest cells for craniofacial development, connecting the enzyme's biochemical function to developmental disease.

   Evidence Cre-lox conditional ablation in neural crest vs. mesoderm, DT-A resistance assay in vivo

   PMID:24895408

   Open questions at the time

   • How diphthamide deficiency on EF-2 leads to neural crest-specific defects (translational target genes) is unknown
   • Whether partial loss of diphthamide modification produces milder phenotypes was not tested
6. 2019 High

   Mutagenesis of the [4Fe-4S] cluster-binding cysteines in each subunit demonstrated that the heterodimer functions asymmetrically: the Dph1 cluster is the catalytic radical SAM center, while the Dph2 cluster facilitates electron relay from the Dph3/Cbr1/NADH system.

   Evidence Site-directed mutagenesis of Fe-S cysteines, EPR spectroscopy, in vitro reconstitution and in vivo complementation

   PMID:31463593

   Open questions at the time

   • Structural basis for asymmetric function awaited high-resolution structure
   • The precise electron transfer pathway from Dph2 to Dph1 was not resolved
7. 2019 Medium

   Functional analysis of patient-derived DPH1 missense variants confirmed that specific mutations compromise catalytic activity and correlate with reduced catalytic site dimensions in a homology model, linking genotype to enzyme dysfunction in DPH1 syndrome.

   Evidence DT ADP-ribosylation assay on seven patient variants, homology modeling and molecular dynamics

   PMID:30877278

   Open questions at the time

   • No experimental crystal structure of human DPH1–DPH2 was available
   • Effect of variants on protein stability vs. catalytic rate was not distinguished
8. 2021 High

   Beyond its electron-donor role, Dph3 was shown to donate iron to restore an air-degraded [3Fe-4S] cluster to a functional [4Fe-4S] state, revealing a dual iron-chaperone/electron-donor mechanism essential for aerobic diphthamide biosynthesis.

   Evidence In vitro reconstitution, EPR spectroscopy, iron quantification

   PMID:34154323

   Open questions at the time

   • Whether other iron chaperones can substitute for Dph3 in vivo is unknown
   • The mechanism of iron transfer from Dph3 to the cluster is not structurally resolved
9. 2023 Medium

   Mutagenesis of the predicted SAM-binding pocket specific to Dph1 identified residues essential for SAM cleavage and ACP radical formation, pinpointing the active site within the heterodimer.

   Evidence Site-directed mutagenesis of SAM-pocket residues, in vivo diphthamide assay, structural modeling

   PMID:38002337

   Open questions at the time

   • No co-crystal structure of DPH1 with SAM has been obtained
   • Kinetic parameters for individual active-site mutants were not measured
10. 2024 Medium

    Tandem cysteine motifs in DPH1 were shown to be critical not only for Fe-S cluster binding but also for structural stability of the heterodimer, as their mutation causes enhanced protein degradation.

    Evidence Site-directed mutagenesis, in vivo diphthamide assay, cycloheximide chase

    PMID:38672486

    Open questions at the time

    • Whether the ubiquitin-proteasome pathway mediates degradation of cluster-deficient DPH1 in this context was not tested
    • Relative contributions of cluster loss vs. misfolding to the functional defect are unclear

• A high-resolution experimental structure of the human DPH1–DPH2 heterodimer, the precise mechanism by which diphthamide deficiency causes neural crest-specific developmental defects (i.e., which mRNAs are mistranslated), and the E3 ligase controlling DPH1 turnover remain unresolved.
• No experimental structure of the human DPH1–DPH2 complex exists
• Translational targets affected by diphthamide loss in neural crest cells are unknown
• The E3 ubiquitin ligase responsible for DPH1 degradation has not been identified